Showing 91–99 of 99 results
-
Health and Herbal Products Development Process and Regulatory Approval 1 March, 2021 Riyadh
1,000.00 SAR Registration -
Pharmaceuticals Pricing SFDA System Explained 3 March, 2021 Riyadh
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 1 June, 2021 Riyadh
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 March, 2022 Riyadh
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 September, 2021 Riyadh
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 22 June, 2022 Riyadh
2,000.00 SAR Registration -
Post Approval Activities and Compliance: Variations Guideline 15 March, 2021 Riyadh
1,500.00 SAR Registration -
Sale!
Preparing VNeeS Submission 11 April, 2021 Riyadh
1,500.00 SAR Registration -
Preparing VNeeS Submission 31 March, 2021 Riyadh
2,000.00 SAR Registration
-
Health and Herbal Products Development Process and Regulatory Approval 1 March, 2021 Riyadh
Understanding drug regulatory affairs in the GCC region is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA and GCC regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
1,000.00 SAR Registration -
Pharmaceuticals Pricing SFDA System Explained 3 March, 2021 Riyadh
The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 1 June, 2021 Riyadh
The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 March, 2022 Riyadh
The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 September, 2021 Riyadh
The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.
2,000.00 SAR Registration -
Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 22 June, 2022 Riyadh
The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.
2,000.00 SAR Registration -
Post Approval Activities and Compliance: Variations Guideline 15 March, 2021 Riyadh
This course will provide an overview and analysis of the various regulatory activities that take place post-approval: In particular, the current regulatory climate will be discussed in depth and numerous examples will be provided to illustrate effective filing of notification techniques. Common issues which have caused difficulties for pharmaceutical firms will also be discussed. The training will discuss in detail the GCC guideline for variations management and post approval commitment.
1,500.00 SAR Registration -
Sale!
Preparing VNeeS Submission 11 April, 2021 Riyadh
This course will offer insight into the compilation of the VNees, share experience and best practices gained during VNees submissions to SFDA.
- Overview of VNees readiness at the agencies
- Impact of the VNees on regulatory processes and procedures
- VNees compilation and life cycle management
- VNees Validation
- Document granularity and readiness
- Technical issues
- Specifications and standards
-
Preparing VNeeS Submission 31 March, 2021 Riyadh
This course will offer insight into the compilation of the VNees, share experience and best practices gained during VNees submissions to SFDA.
- Overview of VNees readiness at the agencies
- Impact of the VNees on regulatory processes and procedures
- VNees compilation and life cycle management
- VNees Validation
- Document granularity and readiness
- Technical issues
- Specifications and standards